Blood Coagulation Disorders Clinical Trial
Official title:
Goal-orientated Therapy of Perioperative Disturbance in Hemostasis With MULTIPLATE and ROTEM in Cardiac Surgery Patients Under Platelets Inhibitors
Verified date | January 2013 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Swissmedic |
Study type | Observational |
Aim of this study is to investigate whether patients preoperatively treated with acetylsalicylic acid and/or clopidogrel have fewer perioperative bleeding and lower amounts of blood substitution when managed by ROTEM (whole blood coagulation analyzer) and MULTIPLATE (thrombocyte function analyzer).
Status | Completed |
Enrollment | 200 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - written consent Exclusion Criteria: - no written consent |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Basel | Basel | CH |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perioperative blood loss | 24 hours | No | |
Secondary | perioperative substitution with erythrocyte concentrates, thrombocyte concentrates or fresh frozen plasma | 24 hours and 7 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02239991 -
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
|
N/A | |
Completed |
NCT01435304 -
The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
|
N/A | |
Completed |
NCT00969319 -
Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
|
N/A | |
Completed |
NCT00091494 -
Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA
|
N/A | |
Completed |
NCT00005481 -
Epidemiology of Impaired Coagulant Balance in Diabetes
|
N/A | |
Recruiting |
NCT02379104 -
ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals
|
N/A | |
Withdrawn |
NCT02774317 -
Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months
|
Phase 4 | |
Recruiting |
NCT01930916 -
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
|
N/A | |
Completed |
NCT00168090 -
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
|
Phase 4 | |
Completed |
NCT01787552 -
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02782338 -
The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
|
N/A | |
Unknown status |
NCT01349712 -
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
|
N/A | |
Completed |
NCT01143909 -
Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients
|
N/A | |
Recruiting |
NCT04762550 -
Thrombin Generation in Liver Transplant Surgery
|
||
Withdrawn |
NCT01221389 -
Study Using Plasma for Patients Requiring Emergency Surgery
|
Phase 4 | |
Withdrawn |
NCT00233246 -
Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures
|
Phase 3 | |
Recruiting |
NCT03884725 -
Fibrinogen Concentrate In Children Cardiac Surgery 2
|
Phase 4 | |
Completed |
NCT00086476 -
Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles
|
N/A | |
Completed |
NCT00708435 -
Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy
|
Phase 3 | |
Recruiting |
NCT00214656 -
"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
|
Phase 3 |